Cost-effectiveness of negative-pressure wound therapy in adults with severe open fractures of the lower limb: Evidence from the WOLLF randomized controlled trial

S. Petrou*, B. Parker, J. Masters, J. Achten, J. Bruce, S. E. Lamb, N. Parsons, M. L. Costa, Keith Willett, Damian Griffin, Steven Jeffery, Jill Arrowsmith, Gorav Datta, Mick Dennison, Mark Farrar, Peter Giannoudis, Andrew Gray, Philip Henman, Peter Hull, Umraz KhanCharlotte Lewis, David Loveday, Jitendra Mangwani, Andrew McAndrew, Damian McClelland, Mike McNicholas, David Noyes, Ben Ollivere, Ian Pallister, Keith Porter, Manoj Ramachandran, Rory Rickard, Benedict Rogers, Hemant Sharma, Adel Tavakkolizadeh, Jonathan Young

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    20 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)1392-1401
    Number of pages10
    JournalBone and Joint Journal
    Volume101-B
    Issue number11
    DOIs
    Publication statusPublished (VoR) - 2019

    Fingerprint

    Dive into the research topics of 'Cost-effectiveness of negative-pressure wound therapy in adults with severe open fractures of the lower limb: Evidence from the WOLLF randomized controlled trial'. Together they form a unique fingerprint.

    Cite this